Alethia Young - 09 Jun 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: Director
Signature: /s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol: PTCT
Transactions as of: 09 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Jun 2022, 16:08:43 UTC
Previous filing: 10 Jun 2022
Next filing: 09 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Award	$0	+3,200		$0.000000	3,200	09 Jun 2022	Direct	F1
transaction	PTCT	Common Stock	Award	$0	+1,867	+58%	$0.000000	5,067	09 Jun 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+12,000		$0.000000	12,000	09 Jun 2022	Common Stock	12,000	$27.85	Direct	F3
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+7,000		$0.000000	7,000	09 Jun 2022	Common Stock	7,000	$27.85	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on June 9, 2022 that vest in three equal installments over three years, commencing on June 8, 2023.
F2	Restricted stock units granted on June 9, 2022 that vest on January 7, 2023.
F3	This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022.
F4	This option was granted on June 9, 2022 and vests over seven approximately equal monthly installments, commencing on July 7, 2022.